ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Janssen Completes Acquisition of Investigational Bermekimab from XBiotech
January 06, 2020The Janssen Pharmaceutical Companies of Johnson & Johnson announced the completion of the acquisition of all rights to the investigational compound bermekimab, which has multiple dermatological indications, along with certain employees ... -
Janssen to acquire bermekimab’s rights from XBiotech for $750m
December 10, 2019Janssen Biotech has signed a definitive agreement to buy rights to XBiotech’s investigational monoclonal antibody, bermekimab, for a cash consideration of $750m.
Pharma Sources Insight January 2025
